Information  X 
Enter a valid email address

Quixant PLC (QXT)

  Print      Mail a friend

Tuesday 19 May, 2020

Quixant PLC

Result of AGM

RNS Number : 3917N
Quixant PLC
19 May 2020
 

19 May 2020

 

Quixant plc

("Quixant")

 

Result of AGM

 

Quixant (AIM: QXT), a leading provider of innovative, highly engineered technology products principally for the global gaming and broadcast industries, announces that at the Annual General Meeting held earlier today, all resolutions were passed.

 

Final results of proxy appointments received for the AGM in advance of the meeting are set out below: 

 

 

Chairman of the meeting
FOR

Chairman of the meeting
AGAINST

Chairman's
Discretion

Abstain

 

Cards

Votes

Cards

Votes

Cards

Votes

Cards

Votes

Ordinary Resolution 1

30

52,280,809

0

0

0

0

0

0

Ordinary Resolution 2

30

52,280,809

0

0

0

0

0

0

Ordinary Resolution 3

30

52,280,809

0

0

0

0

0

0

Ordinary Resolution 4

30

52,280,809

0

0

0

0

0

0

Ordinary Resolution 5

30

47,862,857

2

4,417,952

0

0

0

0

Ordinary Resolution 6

30

52,280,809

0

0

0

0

0

0

Ordinary Resolution 7

28

52,265,055

0

0

1

15,000

1

754

Special Resolution 8

28

52,265,055

0

0

1

15,000

1

754

Special Resolution 9

29

52,265,809

0

0

1

15,000

0

0

 

Maximum votes which may be cast: 66,435,060 

 

 

For further information please contact:

 

Quixant plc

Tel: +44 (0)1223 892 696

Jon Jayal, Chief Executive Officer
Guy Millward, Chief Financial Officer

 




 

Nominated Adviser and Broker:


finnCap Ltd

Tel: +44(0)20 7220 0500

Matt Goode / Simon Hicks (Corporate Finance)


Alice Lane (Corporate Broking)

 




 

Financial PR:

Tel: +44 (0)20 3405 0205

Alma PR


John Coles / Susie Hudson / David Ison


 

 

 

 

 

 

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
RAGFLFFEEIIALII

a d v e r t i s e m e n t